123 related articles for article (PubMed ID: 3541213)
1. The clinical investigator and the evolution of the treatment of primary breast cancer.
Carbone PP; Tormey DC
Semin Oncol; 1986 Dec; 13(4):415-24. PubMed ID: 3541213
[No Abstract] [Full Text] [Related]
2. [Therapeutic results obtained with aminoglutethimide in advanced-stage breast cancer. Factors predictive of a response].
Paridaens RJ; Arrigo C; Heuson JC
Acta Clin Belg Suppl; 1986; 11():18-28. PubMed ID: 3459320
[No Abstract] [Full Text] [Related]
3. [Surgical, radiation and drug treatment of breast cancer].
Pereslegin IA; Nikitina TP
Med Radiol (Mosk); 1990 Jun; 35(6):39-44. PubMed ID: 2192219
[No Abstract] [Full Text] [Related]
4. Estrogen and progesterone receptors in human breast cancer.
Seckinger D
J Fla Med Assoc; 1980 Feb; 67(2):198-202. PubMed ID: 7359111
[No Abstract] [Full Text] [Related]
5. [Improvement of survival due to adjuvant therapy in patients with operable breast carcinoma].
Repelaer van Driel OJ; Welvaart K; Stijnen T
Ned Tijdschr Geneeskd; 1986 Apr; 130(16):744-6. PubMed ID: 3713882
[No Abstract] [Full Text] [Related]
6. The role of progestins and progesterone receptors in the treatment of breast cancer.
Sedlacek SM; Horwitz KB
Steroids; 1984 Dec; 44(6):467-84. PubMed ID: 6400150
[No Abstract] [Full Text] [Related]
7. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
8. Current strategies in operable breast cancer.
Deckers PJ
Hosp Pract (Off Ed); 1987 Jan; 22(1A):41-9, 53-4, 59-68. PubMed ID: 3100553
[No Abstract] [Full Text] [Related]
9. [Breast neoplasms: endocrine therapy and importance of steroid hormone receptors].
Maass H; Jonat W
MMW Munch Med Wochenschr; 1979 Nov; 121(44):1444-7. PubMed ID: 118334
[No Abstract] [Full Text] [Related]
10. Radiotherapy after breast-conservation surgery: how much is enough?
Deutsch M
Semin Surg Oncol; 1992; 8(3):140-6. PubMed ID: 1496224
[TBL] [Abstract][Full Text] [Related]
11. [Medical treatment of the breast].
Battelli T; Manocchi P; Guistini L; Mattioli R; Ginnetti A
Minerva Med; 1984 Feb; 75(6):227-33. PubMed ID: 6231491
[No Abstract] [Full Text] [Related]
12. [Endocrine therapy in breast carcinoma].
Dogliotti L; Maschietto M; Ortega C
Minerva Chir; 1988 Sep; 43(18 Suppl):63-6. PubMed ID: 3067123
[No Abstract] [Full Text] [Related]
13. [Diagnosis and therapy of breast cancer].
Judmaier F; Manfreda D
Wien Med Wochenschr; 1981 Dec; 131(23-24):571-4. PubMed ID: 7336750
[No Abstract] [Full Text] [Related]
14. Cancer of the breast: the past decade (second of two parts).
Henderson IC; Canellos GP
N Engl J Med; 1980 Jan; 302(2):78-90. PubMed ID: 7350436
[No Abstract] [Full Text] [Related]
15. Isolated loss of hormonal receptors in leptomeningeal metastasis from estrogen receptor- and progesterone receptor-positive lobular breast cancer.
Grewal J; Zhou H; Factor R; Kesari S
J Clin Oncol; 2010 May; 28(13):e200-2. PubMed ID: 20124173
[No Abstract] [Full Text] [Related]
16. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
[TBL] [Abstract][Full Text] [Related]
17. [Conservative treatment of breast cancer].
Veronesi U
Chirurg; 1985 Apr; 56(4):269-75. PubMed ID: 3996098
[No Abstract] [Full Text] [Related]
18. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapy for micrometastatic breast cancer.
Lindgren T; Haskell CM
Cancer Invest; 1987; 5(3):205-13. PubMed ID: 2443225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
